Article
HLA-G gene editing: a novel therapeutic alternative in cancer immunotherapy
2021-01-22
Abstract excerpt
Cancer immunotherapies based mainly on the blockade of immune-checkpoint (IC) molecules by anti-IC antibodies offer new alternatives for treatment in oncological diseases. However, a considerable proportion of patients remain unresponsive to them. Hence, the development of novel clinical immunotherapeutic approaches and/or targets are crucial. In this context, targeting the immune-checkpoint HLA-G/ILT2/ILT4 has ca...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f0e76efc-98aa-5991-a8d0-e0275aed7c02
- DOI
- 10.1101/2021.01.21.427294
